| Primary information |
|---|
| Hemolytik ID | 1465 |
| PMID | 20176897 |
| YEAR | 2010 |
| SEQUENCE | G-ΔF-RK-ΔF-KA-ΔF-WH |
| LENGTH | 10 |
| NAME | ΔFmscr |
| C-ter Modification | Amidation |
| N-ter Modification | Acetylation |
| Linear/Cyclic | Linear |
| Stereochemistry | L |
| Modified Residues | ΔF=α,β-didehydrophenylalanine |
| FUNCTION | Antibacterial |
| ACTIVITY | 0% hemolysis upto 679μg/ml(non-hemolytic) |
| RBCs SOURCE | Human |
| Secondary information |
|---|
| Properties | Physico-Chemical details |
| STRUCTURE | |
| DSSP states | NA |
| SMILES | NA |
| External Links |
|---|
| PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
| NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|
| Reference Informaiton |
|---|
| ARTICLE | Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectivity of de novo-designed antimicrobial peptides. |
| AUTHORS | Anantharaman A,Rizvi MS |
| JOURNAL | Antimicrob Agents Chemother. 2010 May;54(5):1693-9. doi: 10.1128/AAC.01231-09. Epub 2010 Feb 22. |
